Karalicin
* Please be kindly noted products are not for therapeutic use. We do not sell to patients.
| Category | Antibiotics |
| Catalog number | BBF-01532 |
| CAS | |
| Molecular Weight | 284.30 |
| Molecular Formula | C14H20O6 |
Online Inquiry
Capabilities & Facilities
Fermentation Lab
4 R&D and scale-up labs
2 Preparative purification labs
Fermentation Plant
Semi pilot, pilot and industrial plant 4 Manufacturing sites 7 Production lines at pilot scale 100+ Reactors of 30-4000 L; 170+ reactors of 20 KL-30 KL; 24+ reactors of >100 KL 2 Hydrogenation reactors (200 L, 4Mpa and 1000L, 4Mpa)
Product Description
Karalicin is produced by the strain of Pseudomonus fluorescens/putida SS-3. It inhibits herpes simplex virus HSV-1, HSV-2, vaccinia virus, polio virus type I with the IC50 (μg/mL) of 0.004, 0.008, 0.016 and 0.016.
- Specification
- Properties
- Reference Reading
- Price Product List
| Synonyms | 3-O-Acetyl-1-deoxy-1-(4-methoxyphenyl)pentitol |
| IUPAC Name | [1,2,4-trihydroxy-5-(4-methoxyphenyl)pentan-3-yl] acetate |
| Canonical SMILES | CC(=O)OC(C(CC1=CC=C(C=C1)OC)O)C(CO)O |
| InChI | InChI=1S/C14H20O6/c1-9(16)20-14(13(18)8-15)12(17)7-10-3-5-11(19-2)6-4-10/h3-6,12-15,17-18H,7-8H2,1-2H3 |
| InChI Key | JATBUOZGJQJSGA-UHFFFAOYSA-N |
| Appearance | Brown Powder |
| Antibiotic Activity Spectrum | viruses |
| Melting Point | 134-136°C |
| BBF-00693 | Ansamitocin P-3 | Inquiry |
| BBF-03211 | AT-265 | Inquiry |
| BBF-03816 | Milbemycin oxime | Inquiry |
| BBF-01210 | Emericid | Inquiry |
| BBF-05808 | Triptolide | Inquiry |
| BBF-01825 | Loganin | Inquiry |
Bio Calculators
Concentration (start) x Volume (start) = Concentration (final) x Volume (final)
It is commonly abbreviated as: C1V1 = C2V2
